Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended by SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018 read with the Code of Practice and ....
Awaiting price reaction for this filing.
Kids Medical Systems has informed BSE that the trading window for its shares is being closed from April 1, 2026, in line with SEBI's Prohibition of Insider Trading Regulations. The restriction applies to designated persons, including Directors, Auditors, and their immediate relatives. The window will reopen 48 hours after the company declares its audited (standalone) financial results for the quarter and financial year ended March 31, 2026. The date of the Board Meeting to approve these results will be communicated separately. The notice is signed by Managing Director Neha Kishor Gokhru.
This is a routine, mandatory compliance notice and carries no material impact on the stock. It temporarily prevents insiders from trading ahead of the FY2026 results, signalling that audited numbers are forthcoming.